Literature DB >> 23963029

Declining cholecystectomy rate during the era of statin use in Finland: a population-based cohort study between 1995 and 2009.

S Suuronen1, L Niskanen, P Paajanen, H Paajanen.   

Abstract

BACKGROUND AND AIMS: Aging with comorbidities, obesity, and rapid recovery from operation may increase the need for laparoscopic cholecystectomy, but long-term use of statins may be associated with a decreased risk of gallstones. This population-based cohort study presents the changing rate and causative factors of laparoscopic cholecystectomy in Finland during the era of statin use.
MATERIALS AND METHODS: Age structure of the population, changes in body mass index and diabetes, and the number of all cholecystectomies in 1995-2009 were retrieved from the registers of National Institute for Health and Welfare. Additionally, these results were supplemented by a population-based retrospective cohort (1581 laparoscopic cholecystectomy) in one community-based hospital area. The risk factors for laparoscopic cholecystectomy, use of statins, and surgical outcome were analyzed.
RESULTS: During the 15 years, 123,794 cholecystectomies were performed in Finland, of which 94,740 (76.5%) were performed using laparoscopic technique. The median rate of laparoscopic cholecystectomy varied between 110 and 140 operations per 100,000 inhabitants. In 1995-2009, the annual number of cholecystectomies decreased from 8600 to 7500, the number of laparoscopic cholecystectomies increased by 10%, and the number of open cholecystectomies declined by 60%. In a cohort of 1581 laparoscopic cholecystectomies, the proportion of elderly (>65 years of age), obese (body mass index > 30 kg/m(2)), and diabetic patients increased from 17% to 28%, 9% to 34%, and 4% to 8%, respectively. Use of statins increased more than fourfold during the 15 years.
CONCLUSIONS: The rates of all cholecystectomies decreased despite marked increase in laparoscopic cholecystectomies performed. The increase in risk factors for gallstones in Finland implied more marked increase in laparoscopic cholecystectomies. The possible role of statins on gallstone disease is discussed.

Entities:  

Keywords:  Cholecystectomy; diabetes; laparoscopic cholecystectomy; obesity; statins

Mesh:

Substances:

Year:  2013        PMID: 23963029     DOI: 10.1177/1457496913492463

Source DB:  PubMed          Journal:  Scand J Surg        ISSN: 1457-4969            Impact factor:   2.360


  5 in total

1.  Statin use and reduced risk of biliary tract cancers in the UK Clinical Practice Research Datalink.

Authors:  Zhiwei Liu; Rotana Alsaggaf; Katherine A McGlynn; Lesley A Anderson; Huei-Ting Tsai; Bin Zhu; Yue Zhu; Sam M Mbulaiteye; Shahinaz M Gadalla; Jill Koshiol
Journal:  Gut       Date:  2018-11-17       Impact factor: 23.059

2.  Requirement of preoperative blood typing for cholecystectomy and appendectomy: a systematic review.

Authors:  Michael G Fadel; Ishaan Patel; Lawrence O'Leary; Nebil Behar; James Brewer
Journal:  Langenbecks Arch Surg       Date:  2022-07-02       Impact factor: 2.895

3.  Bleeding complications in cholecystectomy: a register study of over 22,000 cholecystectomies in Finland.

Authors:  S Suuronen; A Kivivuori; J Tuimala; H Paajanen
Journal:  BMC Surg       Date:  2015-08-13       Impact factor: 2.102

4.  Effect of statin use on outcome of symptomatic cholelithiasis: a case-control study.

Authors:  Jukka Pulkkinen; Matti Eskelinen; Vesa Kiviniemi; Tuukka Kotilainen; Markus Pöyhönen; Lasse Kilpeläinen; Pirjo Käkelä; Helena Kastarinen; Hannu Paajanen
Journal:  BMC Gastroenterol       Date:  2014-07-03       Impact factor: 3.067

Review 5.  Recent advances in understanding and managing cholesterol gallstones.

Authors:  Agostino Di Ciaula; Piero Portincasa
Journal:  F1000Res       Date:  2018-09-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.